Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas.
Monica Hermanson(Ludwig Cancer Research), Monica Nistér(Karolinska University Hospital), Andreas von Deimling(German Cancer Research Center), Bengt Westermark(Science for Life Laboratory), Keiko Funa(Uppsala University), Andreas Waha(University Hospital Bonn), Carl Henrik Heldin(Uppsala University), Jens Koopmann(University of Bonn), David N. Louis(Brigham and Women's Hospital), Otmar D. Wiestler(University of Bonn), David Maintz(University of Münster)
PubMed
January 1, 1996
Cited by 224
Related Papers
The 2007 WHO Classification of Tumours of the Central Nervous System
|Acta Neuropathologica|2007|4.6k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
|Physiological Reviews|1999|2.5k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k